Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to $121.2 million.

  • Lifecore Biomedical, Inc. \De\'s Non-Current Debt rose 2021.35% to $121.2 million in Q2 2025 from the same period last year, while for May 2025 it was $121.2 million, marking a year-over-year increase of 2021.35%. This contributed to the annual value of $121.2 million for FY2025, which is 2021.35% up from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Non-Current Debt stood at $121.2 million, which was up 2021.35% from $115.7 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Non-Current Debt's 5-year high stood at $164.9 million during Q2 2021, with a 5-year trough of $79.6 million in Q1 2022.
  • Its 5-year average for Non-Current Debt is $110.1 million, with a median of $105.5 million in 2024.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Non-Current Debt skyrocketed by 6268.46% in 2021 and then tumbled by 4512.41% in 2022.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Non-Current Debt stood at $124.2 million in 2021, then crashed by 35.91% to $79.6 million in 2022, then increased by 15.69% to $92.1 million in 2023, then rose by 20.03% to $110.5 million in 2024, then grew by 9.65% to $121.2 million in 2025.
  • Its Non-Current Debt stands at $121.2 million for Q2 2025, versus $115.7 million for Q1 2025 and $110.5 million for Q4 2024.